Company profile
Ymmunobio
Ymmunobio is innovating cancer treatment with novel therapeutic antibodies.
- Industry
- Biotechnology Research
- Employees
- 8
- Headquarters
- Basel, Basel
- Founded
- 2021
- LinkedIn followers
- 2,142
- Office locations
- 3
Ymmunobio company summary
Ymmunobio is a company in the Biotechnology Research industry, headquartered in Basel, Basel, founded in 2021. On LinkedIn the company has around 8 employees and 2,142 followers. The company lists 3 office locations.
What technology does Ymmunobio use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Ymmunobio
Ymmunobio is a preclinical stage oncology biotech company focused on the development of innovative treatments for cancer patients through new classes of antibodies. Those treatments present a large market potential and broad applicability in solid tumors. Ymmunobio is making extensive progress in developing antibodies that have unique features of fighting cancers.
Where is Ymmunobio located?
Ymmunobio lists 3 office locations.
Compare companies similar to Ymmunobio
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Ymmunobio ymmuno.bio | Biotechnology Research | 8 | 2021 | Basel, Basel |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Ymmunobio
What does Ymmunobio do?
Ymmunobio is a preclinical stage oncology biotech company focused on the development of innovative treatments for cancer patients through new classes of antibodies. Those treatments present a large market potential and broad applicability in solid tumors. Ymmunobio is making extensive progress in developing antibodies that have unique features of fighting cancers.
How many employees does Ymmunobio have?
Ymmunobio has around 8 employees on LinkedIn.
Where is Ymmunobio headquartered?
Ymmunobio is headquartered in Basel, Basel.
Where does Ymmunobio have offices?
Ymmunobio lists 3 office locations, including Basel, Basel, CH; Princeton, NJ, US; Shanghai, CN, CN.
When was Ymmunobio founded?
Ymmunobio was founded in 2021.
Build a lead list from companies like Ymmunobio
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.